InterCure Ltd. (INCR) — Financial statements
Income statement, balance sheet, and cash flow for InterCure Ltd. — annual and quarterly history with growth and margin analysis.
| Metric (ILS Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 270↑13.1% | 239↓32.8% | 356↓8.5% | 389↑76.9% | 220 | |
| Cost of Revenue | 237↑13.6% | 209↓16.7% | 250↑7.2% | 234↑81.7% | 129 | |
| Gross Profit | 33↑9.8% | 30↓71.2% | 105↓32.2% | 155↑70.2% | 91 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.39↓5.8% | 0.41↑6.7% | 0.39↓38.6% | 0.63↓48.8% | 1 | |
| General & Administrative Expenses | 60↓4.4% | 63↓2.1% | 64↓29.9% | 92↑102.5% | 45 | |
| Selling & Marketing Expenses | 20↓6.7% | 22↓1.0% | 22↑291.9% | 6↓31.4% | 8 | |
| SG&A Expenses | 80↓5.0% | 85↓1.9% | 86↓11.4% | 97↑82.0% | 53 | |
| Other Expenses | -54↓538.5% | 12↓79.4% | 60↑822.8% | 7↓21.1% | 8 | |
| Operating Expenses | 26↓72.9% | 97↓33.6% | 147↑40.4% | 104↑65.9% | 63 | |
| Total Costs & Expenses | 263↓13.9% | 306↓22.9% | 397↑17.5% | 338↑76.5% | 191 | |
| Operating Results | ||||||
| Operating Income | 7↑110.0% | -67↓61.7% | -42↓182.1% | 51↑79.6% | 28 | |
| Depreciation & Amortization | 17↑11.6% | 15↑16.7% | 13↑12.5% | 12↑58.2% | 7 | |
| EBITDA | -7↑85.8% | -51↓114.7% | -24↓134.0% | 70↑125.3% | 31 | |
| EBIT | -24↑63.3% | -67↓79.9% | -37↓163.3% | 59↑146.1% | 24 | |
| Interest & Other Income | ||||||
| Net Interest Income | -18↓0.9% | -18↑8.8% | -20↓42.1% | -14↓181.7% | -5 | |
| Interest Income | 2↓42.4% | 3↓40.6% | 5↑438.7% | 0.84↑549.2% | 0.13 | |
| Interest Expense | 20↓4.8% | 21↓14.8% | 24↑64.9% | 15↑191.2% | 5 | |
| Non-Operating Income | 31↑5981.9% | -0.53↑88.2% | -5↑43.1% | -8↓279.4% | 4 | |
| Other Income / Expenses | -51↓152.7% | -20↓2.0% | -20↓190.6% | -7↑28.2% | -9 | |
| Income Before Tax | -44↑49.5% | -87↓42.5% | -61↓239.8% | 44↑134.0% | 19 | |
| Income Tax Expense | -7↑49.6% | -15↓746.4% | 2↑2317.2% | 0.09↓99.2% | 11 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -37↑49.5% | -73↓14.6% | -64↓245.2% | 44↑499.9% | 7 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -36↑47.3% | -68↓9.4% | -62↓238.2% | 45↑855.6% | 5 | |
| Bottom-Line Net Income | -36↑47.3% | -68↓9.4% | -62↓238.2% | 45↑855.6% | 5 | |
| EPS (Basic) | -0.63↑55.6% | -1.42↓4.4% | -1.36↓237.4% | 0.99↑725.0% | 0.12 | |
| EPS (Diluted) | -0.63↑55.6% | -1.42↓4.4% | -1.36↓237.4% | 0.99↑800.0% | 0.11 | |
| Weighted Average Shares | 57↑18.9% | 48↑4.8% | 46↑0.5% | 45↑17.8% | 38 | |
| Weighted Average Diluted Shares | 57↑18.9% | 48↑4.8% | 46↑0.5% | 45↑11.1% | 41 | |
* All figures in Millions of ILS, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.